Caroline Tanner, MD, PhD, FANA
University of California, San Francisco
Caroline M. Tanner, MD, PhD, specializes in movement disorders. Her research includes descriptive epidemiology, environmental and genetic determinants, biomarkers, early detection, nonmotor features and clinical trials. She is co-PI of the home-based TOPAZ fracture prevention study for people with neurodegenerative parkinsonism and the hybrid Micro-PD trial to reduce off periods in people with Parkinson’s disease. She is a member of the Parkinsons Progression Markers Initiative leadership team and PI of PPMI Online, FOUND-PPMI and the online Fox Insight study. She has been fortunate to mentor talented students from many countries, who themselves are now leading researchers and educators worldwide.